MedPath

Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake

Phase 1
Completed
Conditions
Coronary Artery Disease
Interventions
Registration Number
NCT01690884
Lead Sponsor
Vanderbilt University
Brief Summary

The investigators are trying to determine if a single dose of Ticagrelor will increase delivery of intraarterially-infused adenosine into the forearm interstitium, consistent with adenosine reuptake blockade.

Detailed Description

The investigators will compare adenosine interstitial levels using a parallel design study with three groups of subjects. Forearm interstitial adenosine levels will be measured at baseline and after intrabrachial infusion of adenosine at two doses. Subjects will then randomly receive Ticagrelor 180 mg, Dipyridamole 200 mg, or placebo. Two hours later the investigators will repeat the dialysate collections at baseline and after adenosine infusions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
28
Inclusion Criteria
  1. Subjects will be healthy volunteers, without significant pulmonary, cardiovascular gastrointestinal, hematological or renal diseases
  2. Not taking any regular medications
  3. Able to provide signed consent prior to study participation.
Exclusion Criteria
  1. History of asthma
  2. Pregnancy
  3. Exposure to an investigational drug in the last 2 months.
  4. Known hypersensitivity to study medications

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboAdenosineTo determine if there is an increase in adenosine interstitial levels in the forearm.
DipyridamoleAdenosineTo determine if there is an increase in adenosine interstitial levels in the forearm.
TicagrelorAdenosineTo determine if there is an increase in adenosine interstitial levels in the forearm.
Primary Outcome Measures
NameTimeMethod
Interstitial levels of adenosineAfter each dose of intrabrachial adenosine
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Autonomic Dysfunction Center

🇺🇸

Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath